A randomized safety and tolerability trial of artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children
- 1 September 1999
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 93 (5), 543-546
- https://doi.org/10.1016/s0035-9203(99)90376-0
Abstract
Artemisinin derivatives, such as artesunate, have a short half-life and very rapid anti-malarial activity. Theoretically, using such agents in conjunKeywords
This publication has 7 references indexed in Scilit:
- A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children.The American Journal of Tropical Medicine and Hygiene, 1998
- A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian childrenTransactions of the Royal Society of Tropical Medicine and Hygiene, 1998
- Strategies for the prevention of antimalarial drug resistance: Rationale for combination chemotherapy for malariaParasitology Today, 1996
- The Treatment of MalariaNew England Journal of Medicine, 1996
- A randomized trial of chloroquine, amodiaquine and pyrimethamine‐sulphadoxine in Gambian children with uncomplicated malariaTropical Medicine & International Health, 1996
- Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1995
- DECLINE IN SENSITIVITY OF PLASMODIUM FALCIPARUM TO CHLOROQUINE IN THE GAMBIAThe Lancet, 1987